Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer-Reference-Cited by-同舟云学术

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

Published:2016-02-29 Issue:02 Volume:76 Page:147-149
ISSN:0016-5751
Container-title:Geburtshilfe und Frauenheilkunde
language:de
Short-container-title:Geburtshilfe Frauenheilkd

Author:

Harter P.¹,du Bois A.²,Mahner S.¹,Pfisterer J.²,Ortmann O.¹,Marth C.³,Fink D.⁴,Hilpert F.²,Wagner U.¹,Sehouli J.⁵

Affiliation:

1. Arbeitsgemeinschaft Gynäkologische Onkologie Kommission Ovar

2. Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe

3. Arbeitsgemeinschaft Gynäkologische Onkologie Österreich

4. Arbeitsgemeinschaft für Gynäkologische Onkologie und Brustgesundheit, Schweiz

5. Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie

Publisher

Georg Thieme Verlag KG

Subject

Maternity and Midwifery,Obstetrics and Gynaecology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1568169.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer;Bulletin du Cancer;2023-03

2. Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses;Frontiers in Oncology;2022-05-09

3. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Management of Advanced Ovarian Cancer. A Literature Review;European Journal of Gynaecological Oncology;2022

4. Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer;Journal of Gastrointestinal Oncology;2021-04

5. State of the Science: The role of HIPEC in the treatment of ovarian cancer;Gynecologic Oncology;2021-02